Precision System Science Co., Ltd. (TYO:7707)
194.00
+1.00 (0.52%)
May 14, 2025, 3:30 PM JST
Precision System Science Revenue
Precision System Science had revenue of 1.12B JPY in the quarter ending December 31, 2024, with 19.04% growth. This brings the company's revenue in the last twelve months to 4.16B, down -0.07% year-over-year. In the fiscal year ending June 30, 2024, Precision System Science had annual revenue of 3.98B, down -24.61%.
Revenue (ttm)
4.16B
Revenue Growth
-0.07%
P/S Ratio
1.26
Revenue / Employee
26.35M
Employees
158
Market Cap
5.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 3.98B | -1.30B | -24.61% |
Jun 30, 2023 | 5.28B | -2.16B | -29.00% |
Jun 30, 2022 | 7.43B | -1.86B | -20.05% |
Jun 30, 2021 | 9.30B | 4.23B | 83.50% |
Jun 30, 2020 | 5.07B | 686.00M | 15.66% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 869.37B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 993.33B |